Medec Medicare Limited: Driving Global Innovation in Pharmaceutical Manufacturing
Jagran Desk
The National Conference on Unity for Growth – A Collective March Towards Viksit Bharat, held at Bharat Mandapam, set the stage for an inspiring dialogue on India’s path to becoming a developed, inclusive, and self-reliant nation by 2047.
Organized by Brand Vista Consulting, the forum brought together policymakers, industry leaders, innovators, and youth representatives who emphasized collaboration as the cornerstone of progress.
The conference was inaugurated in the presence of Shri Syed Shahnawaz Hussain, Former Union Minister and Member of Parliament. In his keynote address, he underlined the significance of unity and shared responsibility, saying: “A Viksit Bharat cannot be built in isolation—it requires collective ownership of progress by every citizen and sector.”
The event showcased the spirit of Vasudhaiva Kutumbakam (The World is One Family), highlighting the importance of cooperation over competition for sustainable nation-building.
Spotlight on Medec Medicare Limited
Among the distinguished participants was Dr. Deepak Shenoy, Founder & Managing Director of Medec Dragon and Vice Chairman & Managing Director of Medec Medicare Limited, who was recognized as one of India’s Iconic Brand & Leader 2024-25.
Under Dr. Shenoy’s visionary leadership, Medec Medicare Limited has emerged as a global name in pharmaceutical manufacturing. With more than 15 years of experience in marketing, operations, analytics, and financial management, Dr. Shenoy has steered the company into international markets with a strong focus on ethics, innovation, and sustainable practices. His accolades include an Honorary Doctorate from Dr. APJ Abdul Kalam University and an Honorary Professorship at the University of California, Berkeley.
World-Class Contract Manufacturing
Medec Medicare Limited is a leader in third-party contract manufacturing, specializing in pharmaceutical intermediates and advanced APIs across therapeutic categories. Its WHO-GMP certified facilities serve more than 70 countries, including key markets in Japan, APAC, the Middle East, Africa, Europe, and the Americas.
The company’s asset-light business model provides flexibility while catering to high-demand segments such as oncology, cardiovascular, diabetes care, antibiotics, antivirals, and pain management.
Innovation and Sustainability at the Core
A hallmark of Medec’s operations is its commitment to sustainability and innovation. By leveraging biocatalytic conversions, flow chemistry, and energy-efficient processes, the company ensures environmentally responsible production. Its emphasis on research and development fosters future-ready technologies, ensuring product quality, supply chain resilience, and timely global delivery.
Recognitions and Future Outlook
In recognition of its ethical governance, Medec Medicare Limited received the “Most Promising Company in Corporate Governance 2023” award at ASSOCHAM’s national seminar.
With India’s API market witnessing rapid growth, Medec is strategically positioned to capitalize on new opportunities. The company remains committed to advancing healthcare access worldwide, making human life safer and healthier through innovation, quality, and global partnerships.
For media inquiries, interviews, or follow-ups:
Brand Vista Consulting Team
📧 Email: vp@brandvistaconsulting.com
🌐 Website: www.brandvistaconsulting.com